Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide vs Metformin in Newly Diagnosed T2D
NCT03297879Phase 4Completed
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Jan 2013
- Primary completion
- Feb 2016
- Modality
- Peptides
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Beijing Chaoyang Hospital. Started Jan 2013; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03297879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03297879.